FOLFOX6、贝伐单抗和西妥昔单抗在患者中的 II 期试验-猫眼课题宝

FOLFOX6、贝伐单抗和西妥昔单抗在患者中的 II 期试验

批准号：

7604211

负责人：

Allyson Ocean

金额：

$0.64万

依托单位：

WEILL MEDICAL COLL OF CORNELL UNIV

依托单位国家：

美国

项目类别：

财政年份：

2007

资助国家：

美国

项目状态：

已结题

起止时间：

2007-04-01 至 2007-09-16

来源：

https://reporter.nih.gov/project-details/7604211

关键词：

Bevacizumab/Cetuximab Colorectal Cancer Computer Retrieval of Information on Scientific Projects Database Drug Combinations Funding Grant Institution Patients Phase Research Research Personnel Resources Safety Source Survival Rate United States National Institutes of Health response

项目摘要

项目成果

Allyson Ocean的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To determine the safety, feasibility of administration, response and survival rates among patients with advanced colorectal cancer treated with the combination of drugs, Folfox6, Bevacizumab and Cetuximab.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文